Insider: Fordyce Marshall PRESIDENT AND CEO - Vera Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 143,603 | 0 | 143,603 |
| Value | $3,964,878.83 | $0.00 | $3,964,878.83 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/08/2025 | DDS | 1,875 | Direct | COM | $42.00 | $78,750.00 | 143,603 |
| 01/08/2025 | DDS | 9,975 | Direct | COM | $41.53 | $414,296.66 | 143,603 |
| 01/08/2025 | DDS | 5,650 | Direct | COM | $42.03 | $237,488.71 | 143,603 |
| 12/18/2024 | DDS | 3,772 | Direct | COM | $41.33 | $155,883.18 | 85,942 |
| 12/18/2024 | DDS | 2,195 | Direct | COM | $42.35 | $92,949.25 | 85,942 |
| 12/18/2024 | DDS | 4,635 | Direct | COM | $44.03 | $204,093.88 | 85,942 |
| 12/18/2024 | DDS | 5,023 | Direct | COM | $43.52 | $218,609.50 | 85,942 |
| 12/18/2024 | DDS | 1,875 | Direct | COM | $43.81 | $82,143.75 | 85,942 |
| 12/11/2024 | DDS | 14,925 | Direct | COM | $46.91 | $700,149.66 | 85,942 |
| 12/11/2024 | DDS | 700 | Direct | COM | $47.55 | $33,283.74 | 85,942 |
| 12/11/2024 | DDS | 100 | Direct | COM | $47.65 | $4,765.00 | 85,942 |
| 12/11/2024 | DDS | 1,775 | Direct | COM | $46.94 | $83,324.89 | 85,942 |
| 11/25/2024 | DDS | 6,579 | Direct | COM | $47.05 | $309,532.08 | 85,942 |
| 11/25/2024 | DDS | 1,381 | Direct | COM | $48.80 | $67,398.60 | 85,942 |
| 11/25/2024 | DDS | 7,665 | Direct | COM | $48.18 | $369,329.59 | 85,942 |
| 11/25/2024 | DDS | 1,875 | Direct | COM | $48.76 | $91,425.00 | 85,942 |
| 11/25/2024 | DDS | 1,875 | Direct | COM | $49.00 | $91,875.00 | 85,942 |
| 11/13/2024 | DDS | 100 | Direct | COM | $51.20 | $5,120.00 | 85,942 |
| 11/13/2024 | DDS | 3,307 | Direct | COM | $50.28 | $166,280.92 | 85,942 |
| 11/13/2024 | DDS | 12,218 | Direct | COM | $49.54 | $605,313.93 | 85,942 |
| 11/13/2024 | DDS | 1,565 | Direct | COM | $49.59 | $77,603.19 | 85,942 |
| 11/13/2024 | DDS | 1,875 | Direct | COM | $49.50 | $92,811.00 | 85,942 |
| 11/13/2024 | DDS | 310 | Direct | COM | $50.35 | $15,608.81 | 85,942 |
| 11/13/2024 | DDS | 7,500 | Direct | COM | $49.00 | $367,500.00 | 85,942 |
| 11/13/2024 | DDS | 1,875 | Direct | COM | $49.52 | $92,848.50 | 85,942 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research